If you have hyperhidrosis, you've probably tried every over-the-counter option and found them inadequate. Prescription treatments are meaningfully more effective, but they're not all equivalent. This article gives you an honest, evidence-based picture of each treatment option Sere prescribes: what the clinical data actually shows, where the evidence is thin, and what patients should realistically expect.
A note on expectations. None of these are cures. Hyperhidrosis is a chronic condition, and all of these treatments require ongoing use to maintain their effect. Aluminum chloride stops working within days of stopping it. Anticholinergics are the same. This is worth understanding upfront, you're managing a condition, not curing it. The patients who do best are the ones who treat it like any other chronic condition that requires a maintenance protocol.
Aluminum Chloride 20–25%
Aluminum Chloride 20–25%
First-line topical · Strongest evidence base
How it works
Aluminum ions enter sweat gland ducts, cause temporary mechanical obstruction, and over time cause focal atrophy of the secretory cells. It physically blocks the gland from functioning.
Evidence
Decades of clinical use, multiple randomized controlled trials, and is recommended as first-line treatment by both the International Hyperhidrosis Society and the American Academy of Dermatology. For axillary hyperhidrosis specifically, studies show 70–90% of patients see meaningful reduction in sweating with consistent use. Less effective for palmar and plantar hyperhidrosis because the skin is thicker and the overnight application protocol is harder to maintain.
Limitations
Skin irritation is the primary complaint, the alcohol base causes burning and itching, especially in the first few weeks. Application technique matters enormously: it must be applied to completely dry skin at night, covered with a wrap or glove, and washed off in the morning. Patients who apply it to inflamed or recently shaved skin get significantly more irritation. Those who don't follow the protocol often conclude it doesn't work, when they're just applying it wrong.
Honest verdict: Genuinely effective, well-evidenced, low systemic risk. Our strongest product and the right starting point for most patients with axillary hyperhidrosis.
Topical Oxybutynin Gel
Oxybutynin Gel (Topical)
Anticholinergic · Compounded topical formulation
How it works
Oxybutynin is an anticholinergic that blocks the nerve signals that trigger sweat glands. The topical gel form delivers it locally with lower systemic absorption than oral, which is the primary advantage over oral oxybutynin.
Evidence
The evidence base for topical oxybutynin is thinner than for oral oxybutynin. Most of the robust clinical trial data is for the oral formulation. The topical compounded version is used in clinical practice with reported good outcomes, but randomized controlled trial evidence is limited. One notable study, Glaser et al., demonstrated efficacy for facial hyperhidrosis specifically, which is one of the harder areas to treat with aluminum chloride. For facial and palmar hyperhidrosis, topical oxybutynin has a reasonable evidence base.
Side effects
Even topical application causes systemic anticholinergic effects in some patients. Dry mouth is the most commonly reported, as the systemic absorption, while lower than oral, is not zero. Patients who are sensitive to anticholinergic effects may not tolerate this well.
Honest verdict: Works for many patients with a reasonable evidence base, but the side effect profile is real. Better suited to facial and palmar hyperhidrosis than axillary. A good second-line option for patients who haven't responded to aluminum chloride.
Glycopyrronium Bromide (Topical)
Glycopyrronium Bromide (Topical)
FDA-approved precedent via Qbrexza · Strong evidence
How it works
Glycopyrronium is an anticholinergic that blocks the muscarinic receptors on sweat glands, preventing nerve-triggered sweating. The compounded topical version is essentially a more accessible form of Qbrexza, the FDA-approved commercial wipe for axillary hyperhidrosis.
Evidence
The evidence base is strong. Dermira ran large Phase 3 trials for Qbrexza before FDA approval, showing meaningful reduction in axillary sweating with a generally tolerable side effect profile. The compounded version is not FDA-approved itself, it's a compounded formulation of an approved drug, but the active ingredient has robust clinical validation. Glycopyrronium doesn't cross the blood-brain barrier as readily as oxybutynin, which translates to a lower dry mouth burden.
Side effects
Lower dry mouth incidence than oxybutynin. Some patients still experience anticholinergic effects, urinary hesitancy, blurred vision, constipation, but less frequently than with oxybutynin at comparable doses.
Honest verdict: Probably our second strongest product after aluminum chloride. Good evidence, FDA-approved precedent via Qbrexza, and a better tolerability profile than oxybutynin. An excellent choice for patients who can't tolerate aluminum chloride.
Oral Glycopyrrolate
Oral Glycopyrrolate
Systemic anticholinergic · Requires careful titration
Evidence
Well-evidenced for hyperhidrosis. Multiple studies show significant reduction in sweating across multiple body areas. The International Hyperhidrosis Society recommends it as a systemic option for generalized or severe hyperhidrosis that doesn't respond to topical treatments.
Side effects
As a systemic anticholinergic, it causes dry mouth in the majority of patients at therapeutic doses, along with constipation, urinary hesitancy, and blurred vision at higher doses. Most patients can find a dose that balances efficacy with tolerable side effects, but it requires titration and clinical follow-up.
Honest verdict: Genuinely effective and well-evidenced, but needs careful prescribing, starting low, titrating up, with follow-up to manage side effects. Not appropriate as a first-line option. Best suited to patients with generalized or severe hyperhidrosis where topicals haven't provided adequate control.
Oral Oxybutynin
Oral Oxybutynin
Strongest evidence base · Highest side effect burden
Evidence
The most extensively studied systemic treatment for hyperhidrosis. Multiple randomized controlled trials, widely used off-label for decades, and significant real-world data. Studies show 70–80% of patients report meaningful improvement in sweating.
Side effects
The highest side effect burden of anything on our formulary. Dry mouth at therapeutic doses is nearly universal. At higher doses, cognitive effects, brain fog, memory issues, are documented, particularly in older patients. This is the most clinically demanding product to prescribe responsibly.
Honest verdict: It works, the evidence is strong. But it's a later-line option requiring careful patient selection, clear informed consent about side effects, and active follow-up. Should be considered after topical options have been tried.
The Evidence Summary
Here's how the five treatments rank across the dimensions that matter most for clinical decision-making:
| Treatment | Evidence | Tolerability | Best for |
|---|---|---|---|
| Aluminum Chloride 20–25% | Strong | High | Axillary, first-line |
| Glycopyrronium topical | Strong | High | Axillary, second-line |
| Oxybutynin topical | Moderate | Moderate | Facial, palmar HH |
| Oral glycopyrrolate | Strong | Moderate | Severe / generalized |
| Oral oxybutynin | Strong | Lower | Refractory cases |
The retention insight. Patients who churn from treatment are often those who expected a cure and received management instead. Setting expectations correctly at intake, "this will significantly reduce your sweating but requires continued use", improves long-term outcomes more than almost any other single thing we can do clinically. Hyperhidrosis is a chronic condition. The goal is effective, sustainable control.